NEW YORK (GenomeWeb) – Quest Diagnostics today reported a 4 percent increase year over year in its second quarter revenues, as the company narrowly beat consensus analyst estimates on the top and bottom lines.

Quest reported that for the three months ending June 30, it had $1.90 billion in revenues, up from $1.82 billion in the year-ago quarter. The average analyst estimate was for $1.88 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.